Decreased expression of PCDH9 has been reported in glioma [17,18], gastric cancer [19], hepatocellular carcinoma [20], prostate cancer [21] and ovarian cancer [22], among other neoplasms. Here, PCDH9 is linked to prostate carcinoma.